NCT07751731 Survey to Determine Incarcerated Persons' Views on Surrogate Decision Making
| NCT ID | NCT07751731 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institutes of Health Clinical Center (CC) |
| Condition | Healthy Volunteers |
| Study Type | OBSERVATIONAL |
| Enrollment | 75,000 participants |
| Start Date | 2026-11-18 |
| Primary Completion | 2026-12-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75,000 participants in total. It began in 2026-11-18 with a primary completion date of 2026-12-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: About 180,000 of the people in US prisons are over 55 years old. Aging people often cannot make medical decisions on their own. People who cannot make their own decisions must rely on a "surrogate." A surrogate is someone who helps the person's doctor make decisions for them. Researchers want to conduct a survey to ask people in prison who they would like to be their surrogates. But first, they need to find out if their survey questions are clear and easy to understand. Objective: To get imprisoned people's feedback on survey questions about surrogate decision making. Eligibility: People currently imprisoned in a US facility with access to Edovo. They must be able to read and write in English. Design: Participants will answer 26 survey questions. The questions will be on the Edovo Learn software platform. After each question, they will be asked: "Was this question clear? If not, please explain in the box below what you found unclear. Also, if you have any suggestions for how we might make the question clearer, please include them." Participants will be asked to imagine themselves in a situation where they cannot make their own medical decisions. They may skip questions or stop the survey if they want. No information that identifies them will be collected. The survey will take about 15 minutes.
Eligibility Criteria
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Currently incarcerated in a United States facility with Edovo educational tablets 2. Ability to understand the consent form and survey 3. Willingness to give informed consent EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: 1\. Inability to read or write in English
Contact & Investigator
David Wendler, Ph.D.
PRINCIPAL INVESTIGATOR
National Institutes of Health Clinical Center (CC)
Frequently Asked Questions
Who can join the NCT07751731 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Healthy Volunteers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07751731 currently recruiting?
Yes, NCT07751731 is actively recruiting participants. Contact the research team at dwendler@mail.cc.nih.gov for enrollment information.
Where is the NCT07751731 trial being conducted?
This trial is being conducted at Bethesda, United States.
Who is sponsoring the NCT07751731 clinical trial?
NCT07751731 is sponsored by National Institutes of Health Clinical Center (CC). The principal investigator is David Wendler, Ph.D. at National Institutes of Health Clinical Center (CC). The trial plans to enroll 75,000 participants.